Business Wire (Tue, 7:30AM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (May 14, 2013)
-
Business Wire (May 9, 2013)
-
Business Wire (May 8, 2013)
-
Business Wire (Apr 17, 2013)
-
-
Business Wire (Apr 3, 2013)
-
-
Business Wire (Mar 28, 2013)
-
Business Wire (Mar 27, 2013)
-
Business Wire (Mar 13, 2013)
-
Business Wire (Mar 6, 2013)
-
Business Wire (Feb 27, 2013)
-
Business Wire (Feb 26, 2013)
-
Business Wire (Feb 20, 2013)
-
Business Wire (Feb 14, 2013)
-
Business Wire (Feb 6, 2013)
-
Business Wire (Feb 5, 2013)
-
Business Wire (Feb 4, 2013)
To learn more about Seeking Alpha Pro, click here.
-
-
IPO Market Update And OutlookIPO Candy • Wed, Jan 30 -
-
-
-
-
-
-
-
-
-
2012 Biotech IPOs: Age Of The Dreamers?Bioassociate Consulting • Wed, Jul 4, 2012 -
-
-
-
-
-
-
-
-
Business Wire (Tue, 7:30AM)
-
Business Wire (May 14, 2013)
-
Business Wire (May 9, 2013)
-
Business Wire (May 8, 2013)
-
Business Wire (Apr 17, 2013)
-
Business Wire (Apr 3, 2013)
-
Business Wire (Mar 28, 2013)
-
Business Wire (Mar 27, 2013)
-
Business Wire (Mar 13, 2013)
-
Business Wire (Mar 6, 2013)
-
Business Wire (Feb 27, 2013)
-
Business Wire (Feb 26, 2013)
-
Business Wire (Feb 20, 2013)
-
Business Wire (Feb 14, 2013)
-
Business Wire (Feb 6, 2013)
-
Business Wire (Feb 5, 2013)
-
Business Wire (Feb 4, 2013)
-
Business Wire (Jan 22, 2013)
-
Business Wire (Jan 9, 2013)
-
Business Wire (Jan 3, 2013)
VSTM vs. ETF Alternatives
Company Description
We are a biopharmaceutical company focused on discovering and developing proprietary small molecule drugs targeting cancer stem cells in breast and other cancers along with proprietary companion diagnostics. A cancer stem cell is a particularly aggressive type of tumor cell, resistant to... More
